Ken Griffin Brainsway Ltd. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Brainsway Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 67,359 shares of BWAY stock, worth $408,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,359
Previous 26,414
155.01%
Holding current value
$408,869
Previous $171,000
108.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BWAY
# of Institutions
31Shares Held
3.73MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$5.46 Million0.17% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L3837KShares$5.08 Million0.06% of portfolio
-
Essex Investment Management CO LLC Boston, MA325KShares$1.97 Million0.36% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA298KShares$1.81 Million0.38% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny278KShares$1.69 Million0.0% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $100M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...